rs376214235
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006073.4(TRDN):āc.1801C>Gā(p.Pro601Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000104 in 1,417,586 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_006073.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRDN | NM_006073.4 | c.1801C>G | p.Pro601Ala | missense_variant | 33/41 | ENST00000334268.9 | NP_006064.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRDN | ENST00000334268.9 | c.1801C>G | p.Pro601Ala | missense_variant | 33/41 | 1 | NM_006073.4 | ENSP00000333984 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000792 AC: 12AN: 151484Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000365 AC: 4AN: 109606Hom.: 0 AF XY: 0.0000509 AC XY: 3AN XY: 58978
GnomAD4 exome AF: 0.000107 AC: 136AN: 1266102Hom.: 0 Cov.: 26 AF XY: 0.000102 AC XY: 64AN XY: 626750
GnomAD4 genome AF: 0.0000792 AC: 12AN: 151484Hom.: 0 Cov.: 31 AF XY: 0.0000541 AC XY: 4AN XY: 73956
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Feb 12, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2023 | TRDN: PM2, BP4 - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 01, 2018 | A variant of uncertain significance has been identified in the TRDN gene. The P601A variant has not been published as pathogenic or been reported as benign to our knowledge. The P601A variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The P601A variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. However, this substitution occurs at a position that is not conserved and in silico analysis predicts this variant likely does not alter the protein structure/function. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 01, 2016 | The p.Pro601Ala variant in TRDN has not been previously reported in individuals with cardiomyopathy, but has been identified in 1/8918 European chromosomes by t he Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs3 76214235). Computational prediction tools and conservation analysis suggest that the p.Pro601Ala variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, the clinical signif icance of the p.Pro601Ala variant is uncertain. - |
Catecholaminergic polymorphic ventricular tachycardia 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 05, 2022 | This sequence change replaces proline, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 601 of the TRDN protein (p.Pro601Ala). This variant is present in population databases (rs376214235, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with TRDN-related conditions. ClinVar contains an entry for this variant (Variation ID: 229350). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TRDN protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 12, 2023 | The p.P601A variant (also known as c.1801C>G), located in coding exon 33 of the TRDN gene, results from a C to G substitution at nucleotide position 1801. The proline at codon 601 is replaced by alanine, an amino acid with highly similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at